BIOMARIN PHARMACEUTICAL INC: accounts_receivable
| Value | {"amount": 790266000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-09-30) |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:15.642243+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b768fe87-09a0-4b70-b132-fa6974db96c2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001048477-25-000107Retrieved: 2026-08-19T10:17:15.642243+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/accounts-receivable/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b768fe87-09a0-4b70-b132-fa6974db96c2
History
- no predecessors — first report